Wells Fargo’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-353
| Closed | -$237 | – | 7352 |
|
|
2023
Q2 | $237 | Buy |
353
+13
| +4% | +$9 | ﹤0.01% | 6343 |
|
|
2023
Q1 | $473 | Buy |
340
+2
| +0.6% | +$3 | ﹤0.01% | 6246 |
|
|
2022
Q4 | $426 | Sell |
338
-548
| -62% | -$691 | ﹤0.01% | 6100 |
|
|
2022
Q3 | $3K | Sell |
886
-100
| -10% | -$339 | ﹤0.01% | 5776 |
|
|
2022
Q2 | $4K | Sell |
986
-1,926
| -66% | -$7.81K | ﹤0.01% | 5840 |
|
|
2022
Q1 | $35K | Sell |
2,912
-3,958
| -58% | -$47.6K | ﹤0.01% | 5475 |
|
|
2021
Q4 | $134K | Buy |
6,870
+6,508
| +1,798% | +$127K | ﹤0.01% | 5101 |
|
|
2021
Q3 | $10K | Hold |
362
| – | – | ﹤0.01% | 5887 |
|
|
2021
Q2 | $8K | Sell |
362
-93
| -20% | -$2.06K | ﹤0.01% | 5885 |
|
|
2021
Q1 | $11K | Buy |
455
+167
| +58% | +$4.04K | ﹤0.01% | 5957 |
|
|
2020
Q4 | $5K | Buy |
288
+5
| +2% | +$87 | ﹤0.01% | 5859 |
|
|
2020
Q3 | $5K | Buy |
283
+24
| +9% | +$424 | ﹤0.01% | 5701 |
|
|
2020
Q2 | $3K | Buy |
259
+252
| +3,600% | +$2.92K | ﹤0.01% | 5696 |
|
|
2020
Q1 | $0 | Sell |
7
-957
| -99% | – | ﹤0.01% | 6564 |
|
|
2019
Q4 | $11K | Buy |
964
+534
| +124% | +$6.09K | ﹤0.01% | 5556 |
|
|
2019
Q3 | $9K | Sell |
430
-1,168
| -73% | -$24.4K | ﹤0.01% | 5568 |
|
|
2019
Q2 | $37K | Sell |
1,598
-276
| -15% | -$6.39K | ﹤0.01% | 5340 |
|
|
2019
Q1 | $73K | Buy |
1,874
+104
| +6% | +$4.05K | ﹤0.01% | 5141 |
|
|
2018
Q4 | $81K | Buy |
1,770
+231
| +15% | +$10.6K | ﹤0.01% | 5128 |
|
|
2018
Q3 | $210K | Buy |
1,539
+375
| +32% | +$51.2K | ﹤0.01% | 4802 |
|
|
2018
Q2 | $549K | Buy |
+1,164
| New | +$549K | ﹤0.01% | 4284 |
|